Cargando…
Assessment of Two Different Glucagon Assays in Healthy Individuals and Type 1 and Type 2 Diabetes Patients
Methods for glucagon analysis suffered in the past from lack of specificity and a narrow sensitivity range, which has led to inaccurate results and to the suggestion that type 1 diabetes (T1D) and type 2 diabetes (T2D) patients have elevated fasting glucagon levels. However, the availability of more...
Autores principales: | Brunner, Martina, Moser, Othmar, Raml, Reingard, Haberlander, Maximilian, Boulgaropoulos, Beate, Obermayer-Pietsch, Barbara, Svehlikova, Eva, Pieber, Thomas R., Sourij, Harald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946514/ https://www.ncbi.nlm.nih.gov/pubmed/35327658 http://dx.doi.org/10.3390/biom12030466 |
Ejemplares similares
-
EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus
por: Obermayer, Anna, et al.
Publicado: (2021) -
Quantification of the Therapeutic Antibody Ocrelizumab in Mouse Brain Interstitial Fluid Using Cerebral Open Flow Microperfusion and Simultaneous Monitoring of the Blood–Brain Barrier Integrity
por: Altendorfer-Kroath, Thomas, et al.
Publicado: (2023) -
Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial
por: Tripolt, Norbert Joachim, et al.
Publicado: (2018) -
Glucose-Lowering Therapy beyond Insulin in Type 1 Diabetes: A Narrative Review on Existing Evidence from Randomized Controlled Trials and Clinical Perspective
por: Aberer, Felix, et al.
Publicado: (2022) -
Impact of a Single 36 Hours Prolonged Fasting Period in Adults With Type 1 Diabetes – A Cross-Over Controlled Trial
por: Moser, Othmar, et al.
Publicado: (2021)